nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody-drug conjugate [ADC] treatment of leukaemia
|
Hassan, Hassan Tawhid |
|
|
131 |
C |
p. |
artikel |
2 |
Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia
|
Jain, Tania |
|
|
131 |
C |
p. |
artikel |
3 |
Editorial Board
|
|
|
|
131 |
C |
p. |
artikel |
4 |
Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment
|
Wu, Xun |
|
|
131 |
C |
p. |
artikel |
5 |
Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia
|
Martínez-Castillo, Macario |
|
|
131 |
C |
p. |
artikel |
6 |
Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy
|
Atanasio, A. |
|
|
131 |
C |
p. |
artikel |
7 |
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis
|
Mian, Agrima |
|
|
131 |
C |
p. |
artikel |
8 |
Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort
|
Kaynar, Lale Aydın |
|
|
131 |
C |
p. |
artikel |
9 |
Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemia
|
Bade, Rory |
|
|
131 |
C |
p. |
artikel |
10 |
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis
|
Khanna, Vishesh |
|
|
131 |
C |
p. |
artikel |
11 |
Should patients with acute myeloid leukemia treated with venetoclax-based regimens receive antifungal prophylaxis?
|
Guarana, Mariana |
|
|
131 |
C |
p. |
artikel |
12 |
Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)
|
Mangaonkar, Abhishek A. |
|
|
131 |
C |
p. |
artikel |